TY - JOUR
T1 - Suppression of COUP-TFII upregulates angiogenin and promotes angiogenesis in endometriosis
AU - Fu, Jhao Lin
AU - Hsiao, Kuei Yang
AU - Lee, Hsiu Chi
AU - Li, Wan Ning
AU - Chang, Ning
AU - Wu, Meng Hsing
AU - Tsai, Shaw Jenq
N1 - Funding Information:
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by research grants (MOST 105-2314-B-006-059-MY3 to M.H.W. and MOST 104-2320-B-006-036-MY3 to S.J.T.) from the Ministry of Science and Technology, Taiwan. The authors declare that there is no conflict of interest.
Publisher Copyright:
© 2018 The Author(s).
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Study Question: How does hypoxia-mediated downregulation of chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) promote angiogenesis in endometriosis? Summary Answer: Suppression of COUP-TFII by hypoxia stimulates angiogenesis through induction of angiogenin (ANG). What is Known Already: The level of COUP-TFII is downregulated in endometriotic tissues, and downregulation of COUP-TFII contributes to the development of endometriosis. Study Design, Size, Duration: Twenty-seven patients of reproductive age with endometriosis were recruited in this study. Eutopic endometrial and ectopic endometriotic stromal cells were isolated, cultured and subjected to various treatments. Participants/Materials, Setting, Methods: Microarray hybridization, quantitative RT-PCR, and Western blot were used to detect gene expression in normal and endometriotic samples. A luciferase reporter assay and chromatin immunoprecipitation in normoxiaor hypoxia-treated primary cultures of human endometrial stromal cells were performed. Tube formation analysis was performed using primary human umbilical vein endothelial cells (HUVECs). Main Results and the Role of Chance: Protein level of COUP-TFII was downregulated by hypoxia (P > 0.05, normoxia versus hypoxia). Loss of COUP-TFII increased the angiogenic capacity of endometrial stromal cells (P > 0.05, COUP-TFII knockdown versus knockdown control). A novel COUP-TFII target gene, ANG, was identified through microarray analysis. Chromatin immunoprecipitation and promoter activity assays demonstrated that the ANG promoter was bound and suppressed by COUP-TFII (P > 0.05, COUP-TFII overexpression versus empty vector). The levels of ANG mRNA and protein were elevated in ectopic endometriotic stromal cells and negatively correlated with COUP-TFII (P > 0.05, endometrial versus endometriotic tissues/stromal cells). Both knockdown and forced-expression of COUP-TFII further demonstrated that ANG expression and ANG-mediated angiogenic activity were negatively regulated by COUP-TFII (P > 0.05, COUP-TFII knockdown versus knockdown control, and COUP-TFII overexpression versus empty vector). Limitations, Reasons for Caution: This study was conducted in primary human endometrial stromal cell cultures and HUVECs, therefore, may not fully reflect the situation in vivo. Large Scale Data: The raw data were submitted to Gene Expression Omnibus (GSE107469). Wider Implications of the Findings: This is the first study to highlight that the aberrant expression of ANG in endometriotic lesions is mediated by hypoxia-suppressed COUP-TFII expression, which reveals an as yet unidentified molecular pathogenesis of endometriosis. Study Funding/Competing Interest(S): This work was supported by research grants (MOST 105-2314-B-006-059-MY3 to M.H.W. and MOST 104-2320-B-006-036-MY3 to S.J.T.) from the Ministry of Science and Technology, Taiwan. The authors declare that there is no conflict of interest.
AB - Study Question: How does hypoxia-mediated downregulation of chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) promote angiogenesis in endometriosis? Summary Answer: Suppression of COUP-TFII by hypoxia stimulates angiogenesis through induction of angiogenin (ANG). What is Known Already: The level of COUP-TFII is downregulated in endometriotic tissues, and downregulation of COUP-TFII contributes to the development of endometriosis. Study Design, Size, Duration: Twenty-seven patients of reproductive age with endometriosis were recruited in this study. Eutopic endometrial and ectopic endometriotic stromal cells were isolated, cultured and subjected to various treatments. Participants/Materials, Setting, Methods: Microarray hybridization, quantitative RT-PCR, and Western blot were used to detect gene expression in normal and endometriotic samples. A luciferase reporter assay and chromatin immunoprecipitation in normoxiaor hypoxia-treated primary cultures of human endometrial stromal cells were performed. Tube formation analysis was performed using primary human umbilical vein endothelial cells (HUVECs). Main Results and the Role of Chance: Protein level of COUP-TFII was downregulated by hypoxia (P > 0.05, normoxia versus hypoxia). Loss of COUP-TFII increased the angiogenic capacity of endometrial stromal cells (P > 0.05, COUP-TFII knockdown versus knockdown control). A novel COUP-TFII target gene, ANG, was identified through microarray analysis. Chromatin immunoprecipitation and promoter activity assays demonstrated that the ANG promoter was bound and suppressed by COUP-TFII (P > 0.05, COUP-TFII overexpression versus empty vector). The levels of ANG mRNA and protein were elevated in ectopic endometriotic stromal cells and negatively correlated with COUP-TFII (P > 0.05, endometrial versus endometriotic tissues/stromal cells). Both knockdown and forced-expression of COUP-TFII further demonstrated that ANG expression and ANG-mediated angiogenic activity were negatively regulated by COUP-TFII (P > 0.05, COUP-TFII knockdown versus knockdown control, and COUP-TFII overexpression versus empty vector). Limitations, Reasons for Caution: This study was conducted in primary human endometrial stromal cell cultures and HUVECs, therefore, may not fully reflect the situation in vivo. Large Scale Data: The raw data were submitted to Gene Expression Omnibus (GSE107469). Wider Implications of the Findings: This is the first study to highlight that the aberrant expression of ANG in endometriotic lesions is mediated by hypoxia-suppressed COUP-TFII expression, which reveals an as yet unidentified molecular pathogenesis of endometriosis. Study Funding/Competing Interest(S): This work was supported by research grants (MOST 105-2314-B-006-059-MY3 to M.H.W. and MOST 104-2320-B-006-036-MY3 to S.J.T.) from the Ministry of Science and Technology, Taiwan. The authors declare that there is no conflict of interest.
UR - http://www.scopus.com/inward/record.url?scp=85055183103&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055183103&partnerID=8YFLogxK
U2 - 10.1093/humrep/dey220
DO - 10.1093/humrep/dey220
M3 - Article
C2 - 29982401
AN - SCOPUS:85055183103
SN - 0268-1161
VL - 33
SP - 1517
EP - 1527
JO - Human Reproduction
JF - Human Reproduction
IS - 8
ER -